RESULT OF GENERAL MEETING AND DIRECTORS DEALING

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.

Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy

To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.

Resolution	Votes For	Votes at Chairman's Discretion	Votes at other proxy Discretion	Votes Against	Votes Withheld	Total votes cast	Result

Ordinary resolution
1	677,773,077	995,046	11,700	569,956	18,474	679,368,253	Passed

Special resolution
2	677,820,393	589,675	11,700	309,110	637,375	679,368,253	Passed

Ordinary resolution
3	313,817,070	689,296	11,700	664,606	185,581	315,368,253	Passed

Name of Director	Title	Number of Ordinary Shares Purchased	Number of Ordinary Shares beneficially held immediately following Admission	Percentage of issued ordinary shares beneficially held immediately following Admission
Nick Rodgers	Non-Executive Chairman	200,000	1,042,829	0.04%
John Dawson	Chief Executive Officer	500,000	2,782,829	0.11%
Peter Nolan	Senior Vice President, Commercial Development	150,000	883,313	0.04%
Tim Watts	Chief Financial Officer	1,625,000	5,307,829	0.21%
Dr. Paul Blake	Non-Executive Director	1,250,000	1,783,097	0.07%
Dr. Andrew Heath	Non-Executive Director	250,000	850,000	0.03%
Martin Diggle ¹	Non-Executive Director	132,250,000	533,250,100 ²	21.38% ²

For further information, please contact:
Oxford BioMedica plc: John Dawson, Chief Executive Officer Tim Watts, Chief Financial Officer	Tel: +44 (0)1865 783 000

Media Enquiries: Mary-Jane Elliott/Emma Thompson/Matthew Neal Consilium Strategic Communications	Tel: +44 (0)20 3709 5700

Companies

UK 100

Latest directors dealings